Variability in surgical outcomes by day of the week has only recently been investigated in urology. A Cleveland Clinic urologist examines data in BPH outcomes over a 15-year period, controlling for surgeon and experience, shares theories on notable differences and notes what physicians can do next to ensure consistency across every day of the week.
Office-based and surgical treatments for benign prostatic hyperplasia cost the same as just a few years of combination medical therapy, a recent Cleveland Clinic study shows. The results should inform conversations with patients about upfront therapy options.
Despite its many benefits, HoLEP hasn’t been as widely adopted in the U.S. as it should be. Urologist Smita De, MD, PhD, explains why she believes the technique deserves a reexamination.
Surgery for BPH can help men averse to a lifetime of medication use avoid the hassle. This study helps answer the question: Which type of procedure is most effective in helping men discontinue meds?
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Several innovative techniques addressing BPH have ushered in a new era of patient-friendly treatments with potential for fewer side effects. Urologists continue to refine them.